Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina

Acta Diabetologica

Volumn 53, Issue 1, 2016, Pages 81-89

  Qiu, Yi ^a   Zhao, Di ^a   Butenschön, Vicki Marie ^a   Bauer, Alexander T ^a   Schneider, Stefan W ^a   Skolnik, Edward Y ^b   Hammes, Hans Peter ^a   Wieland, Thomas ^a   Feng, Yuxi ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiopoietin 2; Diabetic retinopathy; Nucleoside diphosphate kinase B; O linked acetylglucosamine; Retina

Indexed keywords

ANGIOPOIETIN 2; GLUCOSE; N ACETYLGLUCOSAMINE; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE B; UNCLASSIFIED DRUG; HEXOSAMINE; NME2 PROTEIN, MOUSE; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

ACELLULAR CAPILLARY; ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL LOSS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISORDERS OF CARBOHYDRATE METABOLISM; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; RETINAL VASCULAR DAMAGE; UPREGULATION; VASCULAR DISEASE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; COMPLICATION; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; RETINA BLOOD VESSEL; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOPOIETIN-2; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; GLUCOSE; HEXOSAMINES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; MALE; MICE; MICE, KNOCKOUT; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PERICYTES; RETINA; RETINAL VESSELS; UP-REGULATION;

EID: 84957961431     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-015-0752-x     Document Type: Article

References (46)

1. Lascu I, Gonin P (2000) The catalytic mechanism of nucleoside diphosphate kinases. J Bioenerg Biomembr 32(3):237–246
2. Gilles AM, Presecan E, Vonica A, Lascu I (1991) Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 266(14):8784–8789
3. Janin J, Dumas C, Morera S, Xu Y, Meyer P, Chiadmi M, Cherfils J (2000) Three-dimensional structure of nucleoside diphosphate kinase. J Bioenerg Biomembr 32(3):215–225
4. Cipollini G, Berti A, Fiore L, Rainaldi G, Basolo F, Merlo G, Bevilacqua G, Caligo MA (1997) Down-regulation of the nm23.h1 gene inhibits cell proliferation. Int J Cancer 73(2):297–302
5. Fournier HN, Albiges-Rizo C, Block MR (2003) New insights into Nm23 control of cell adhesion and migration. J Bioenerg Biomembr 35(1):81–87
6. Gervasi F, D’Agnano I, Vossio S, Zupi G, Sacchi A, Lombardi D (1996) nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor. Cell Growth Differ 7(12):1689–1695
7. Kang Y, Lee DC, Han J, Yoon S, Won M, Yeom JH, Seong MJ, Ko JJ, Lee KA, Lee K, Bae J (2007) NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling. Biochem Biophys Res Commun 359(1):76–82
8. Krishnan KS, Rikhy R, Rao S, Shivalkar M, Mosko M, Narayanan R, Etter P, Estes PS, Ramaswami M (2001) Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron 30(1):197–210
9. Palacios F, Schweitzer JK, Boshans RL, D’Souza-Schorey C (2002) ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol 4(12):929–936
10. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54(6):1615–1625
11. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80:825–858
12. Feng Y, Gross S, Wolf NM, Butenschon VM, Qiu Y, Devraj K, Liebner S, Kroll J, Skolnik EY, Hammes HP, Wieland T (2014) Nucleoside diphosphate kinase B regulates angiogenesis through modulation of vascular endothelial growth factor receptor type 2 and endothelial adherens junction proteins. Arterioscler Thromb Vasc Biol 34(10):2292–2300
13. Hammes HP, Feng Y, Pfister F, Brownlee M (2011) Diabetic retinopathy: targeting vasoregression. Diabetes 60(1):9–16
14. Feng Y, Pfister F, Schreiter K, Wang Y, Stock O, Vom Hagen F, Wolburg H, Hoffmann S, Deutsch U, Hammes HP (2008) Angiopoietin-2 deficiency decelerates age-dependent vascular changes in the mouse retina. Cell Physiol Biochem 21(1–3):129–136
15. Feng Y, Vom Hagen F, Wang Y, Beck S, Schreiter K, Pfister F, Hoffmann S, Wagner P, Seeliger M, Molema G, Deutsch U, Hammes HP (2009) The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy. Thromb Haemost 102(1):120–130
16. Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M, Deutsch U (2004) Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 53(4):1104–1110
17. Pfister F, Feng Y, Vom Hagen F, Hoffmann S, Molema G, Hillebrands JL, Shani M, Deutsch U, Hammes HP (2008) Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 57(9):2495–2502
18. Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, Suske G, Rabbani N, Thornalley PJ, Sarthy VP, Hammes HP, Brownlee M (2007) High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 282(42):31038–31045
19. Di L, Srivastava S, Zhdanova O, Sun Y, Li Z, Skolnik EY (2010) Nucleoside diphosphate kinase B knock-out mice have impaired activation of the K+ channel KCa3.1, resulting in defective T cell activation. J Biol Chem 285(50):38765–38771
20. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51(10):3107–3112
21. Kroll J, Epting D, Kern K, Dietz CT, Feng Y, Hammes HP, Wieland T, Augustin HG (2009) Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis. Am J Physiol Heart Circ Physiol 296(3):H893–H899
22. Feng Y, Vom Hagen F, Pfister F, Djokic S, Hoffmann S, Back W, Wagner P, Lin J, Deutsch U, Hammes HP (2007) Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb Haemost 97(1):99–108
23. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000) The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32(3):247–258
24. Hsu T, Steeg PS, Zollo M, Wieland T (2015) Progress on Nme (NDP kinase/Nm23/Awd) gene family-related functions derived from animal model systems: studies on development, cardiovascular disease, and cancer metastasis exemplified. Naunyn Schmiedebergs Arch Pharmacol 388(2):109–117
25. Attwood PV, Wieland T (2015) Nucleoside diphosphate kinase as protein histidine kinase. Naunyn Schmiedebergs Arch Pharmacol 388(2):153–160
26. Berberich SJ, Postel EH (1995) PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Oncogene 10(12):2343–2347
27. Hippe HJ, Wolf NM, Abu-Taha HI, Lutz S, Le Lay S, Just S, Rottbauer W, Katus HA, Wieland T (2011) Nucleoside diphosphate kinase B is required for the formation of heterotrimeric G protein containing caveolae. Naunyn Schmiedebergs Arch Pharmacol 384(4–5):461–472
28. Hippe HJ, Wolf NM, Abu-Taha I, Mehringer R, Just S, Lutz S, Niroomand F, Postel EH, Katus HA, Rottbauer W, Wieland T (2009) The interaction of nucleoside diphosphate kinase B with Gbetagamma dimers controls heterotrimeric G protein function. Proc Natl Acad Sci USA 106(38):16269–16274
29. Rayner K, Chen YX, Hibbert B, White D, Miller H, Postel EH, O’Brien ER (2007) NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression with progression of atherosclerosis. Am J Physiol Regul Integr Comp Physiol 292(2):R743–R750
30. Rayner K, Chen YX, Hibbert B, White D, Miller H, Postel EH, O’Brien ER (2008) Discovery of NM23-H2 as an estrogen receptor beta-associated protein: role in estrogen-induced gene transcription and cell migration. J Steroid Biochem Mol Biol 108(1–2):72–81
31. Fournier HN, Dupe-Manet S, Bouvard D, Lacombe ML, Marie C, Block MR, Albiges-Rizo C (2002) Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J Biol Chem 277(23):20895–20902
32. Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S (2004) Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103(12):4536–4544
33. Buxton IL, Yokdang N (2011) Extracellular NM23 signaling in breast cancer: incommodus verum. Cancers (Basel) 3(3):2844–2857
34. Yokdang N, Tellez JD, Tian H, Norvell J, Barsky SH, Valencik M, Buxton IL (2011) A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling. Br J Cancer 104(10):1628–1640
35. Pfister F, Wang Y, Schreiter K, Vom Hagen F, Altvater K, Hoffmann S, Deutsch U, Hammes HP, Feng Y (2010) Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol 47(1):59–64
36. Jones SE, Jomary C, Grist J, Stewart HJ, Neal MJ (2000) Identification by array screening of altered nm23-M2/PuF mRNA expression in mouse retinal degeneration. Mol Cell Biol Res Commun MCBRC 4(1):20–25
37. Postel EH, Berberich SJ, Rooney JW, Kaetzel DM (2000) Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr 32(3):277–284
38. Steeg PS, Zollo M, Wieland T (2011) A critical evaluation of biochemical activities reported for the nucleoside diphosphate kinase/Nm23/Awd family proteins: opportunities and missteps in understanding their biological functions. Naunyn Schmiedebergs Arch Pharmacol 384(4–5):331–339
39. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115(9):2382–2392
40. Wieland T (2007) Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: consequences on G protein activation and stability. Naunyn Schmiedebergs Arch Pharmacol 374(5–6):373–383
41. Wieland T, Nurnberg B, Ulibarri I, Kaldenberg-Stasch S, Schultz G, Jakobs KH (1993) Guanine nucleotide-specific phosphate transfer by guanine nucleotide-binding regulatory protein beta-subunits. Characterization of the phosphorylated amino acid. J Biol Chem 268(24):18111–18118
42. Wang HZ, Wu KY, Lin CP, Fong JC, Hong SJ (1997) Alteration of glucose uptake in cultured human corneal endothelial cells grown in high glucose media via cAMP-dependent pathway. Kaohsiung J Med Sci 13(9):566–571
43. Hart GW, Akimoto Y (2009) The O-GlcNAc modification. In: Varki A, Cummings RD, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, New York
44. Kowluru A, Kowluru RA, Yamazaki A (1992) Functional alterations of G-proteins in diabetic rat retina: a possible explanation for the early visual abnormalities in diabetes mellitus. Diabetologia 35(7):624–631
45. Klaassen I, Hughes JM, Vogels IM, Schalkwijk CG, Van Noorden CJ, Schlingemann RO (2009) Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Exp Eye Res 89(1):4–15
46. Kern TS, Du Y, Miller CM, Hatala DA, Levin LA (2010) Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 176(5):2550–2558